The findings predict that the total number of West Nile Virus cases will increase, and be more geographically widespread, across New York and Connecticut in future years due to warming trends.
Tony Teixeira from Danbury, Connecticut had minimally invasive robotic surgery to remove a rare heart tumor.
An 86-year old woman from Danbury, Connecticut had Transcatheter Aortic Valve Replacement (TAVR) to treat severe aortic stenosis. TAVR is a minimally invasive procedure that is a safe alternative for patients who are at intermediate to high risk of complications from open heart surgery.
Norwalk Hospital same day total joint replacement surgery leaves patient highly active and pain-free
Just as the scientific community was reaching a consensus on the dangerous reality of climate change, the partisan divide on climate change began to widen.
After Cynthia Vetter鈥檚 husband鈥攁 highway patrol officer鈥攚as fatally shot in Texas during a routine traffic stop in 2000, the tragedy inspired the creation of Dallas-based COPsync, Inc. The company has created the COPsync Network, with applications that enable law enforcement patrol officers to communicate in real-time on the Network; and COPsync911, which is activated by school staff when a threatening situation arises, and allows the staff to send an immediate and silent alert to all other staff, the local law enforcement dispatch center and the closest law enforcement officers in their patrol cars.
Expert can discuss drone package delivery and why launching delivery drones from local delivery trucks can make the drone flights short, effective, safe and extremely economical.
Halloween and candy go hand in hand. You might say the same about candy and cavities. That's why smart toothbrush company Kolibree suggests you pay attention to your oral hygiene as we approach Halloween during National Dental Hygiene Month.
Expert can discuss the ways in which industries that produce low-BTU waste gases (such as methane) can remain profitable even while adopting the EPA鈥檚 new Clean Power Plan, and how the technology developed by his company, Ener-Core, Inc., can play a key role in effective this positive change.
Expert can speak about the need for better technological solutions to keep law enforcement officers safe to help them interdict criminals traveling throughout the U.S., as well as systems such as the COPsync Network that are already in use in various states.
Expert can discuss the need to address the issue of heroin and prescription opioid abuse by developing innovative medical treatments. Specifically, he can describe the features and benefits of an inside-the-cheek format of buprenorphine for the maintenance treatment of opioid addiction.
Epilepsy Currents is a literature surveillance publication, including brief expert commentary on abstracts in selected basic science and clinical topics selected by the editorial board.
Expert can discuss school safety and how a new technology, the COPsync911 threat notification system, that connects a school or other facility under threat directly to the closest patrol officers and local dispatch during an episode of violence鈥攅nsuring law enforcement is on the scene faster than 911鈥攁nd potentially mitigating the liability faced by schools in states like Colorado, which have passed legislation to allow lawsuits against schools when shootings or other violence occurs.
Today the American Epilepsy Society (AES) announced Anis Contractor, Ph.D., Associate Professor of Physiology at Northwestern University, Feinberg School of Medicine, as the recipient of a 2015 AES Seed Grant. Dr. Contractor鈥檚 proposed research seeks to address a fundamental question about cellular and circuit level excitability in the mouse model of Dravet Syndrome.
The American Epilepsy Society (AES) announced Alan B. McMillan, Ph.D., Principal Investigator in the Department of Radiology at the University of Wisconsin School of Medicine and Public Health, as the recipient of a 2015 AES Seed Grant. Dr. McMillan鈥檚 winning proposal seeks to obtain early preliminary data of neurodegeneration in chronic epilepsy using simultaneous Positron Emission Tomography (PET) and Magnetic Resonance (MR) imaging.
Expert can speak on the need for treatment of pain with less potential for abuse than existing painkillers; for better options for those already dealing with opioid dependence; and for the need to address patients鈥� lifestyles as well as bodies to ensure optimal treatment. Dr. Mark Sirgo is president and CEO of BioDelivery Sciences, whose FDA-approved drug BUNAVAIL and investigational drug BELBUCA allow for the efficient delivery of buprenorphine while potentially overcoming some of the administration challenges presented by sublingual dosage forms, and whose Inreach Assist website and app offers a comprehensive array of information and resources to support patients dealing with addiction and their families.
Leigh N. Sepeta, Ph.D., Children鈥檚 National Health System, was awarded the Susan S. Spencer Clinical Research Training Fellowship for her work in temporal lobe epilepsy in pediatric patients. Dr. Sepeta will receive this distinguished honor at an award ceremony to take place during the American Academy of Neurology鈥檚 (AAN) Annual Meeting later this month. Dr. Sepeta was also recognized for this award during the American Epilepsy Society Annual Meeting.
Epilepsy affects nearly 30 percent of all people with autism spectrum disorder (ASD), a neurobehavioral condition marked by impaired social and language development. Conversely, many patients with epilepsy display ASD-like behavior. Recent studies suggest that epileptic seizures impair the neural pathways needed for socialization, but the details of this process remain unclear.
New trends and cutting-edge research in epilepsy will be highlighted in an Invited Science Session on April 23 from 1:00 鈥� 2:45 p.m. at the American Academy of Neurology鈥檚 2015 Annual Meeting in Washington, DC. The Invited Science Session will feature 20-minute platform presentations from authors of five groundbreaking studies presented at the American Epilepsy Society鈥檚 recent Annual Meeting.
An expert can speak on how treating sleep problems might reduce the potential of PTSD among military personnel. Seth Lederman, MD, co-founder and CEO of Tonix Pharmaceuticals Holding Corp., is overseeing the development of TNX-102 SL, an advanced sublingual reformulation of the FDA-approved muscle relaxant cyclobenzaprine, aiming to improve sleep quality and make a meaningful difference in the symptoms experienced by PTSD patients. Tonix鈥檚 AtEase Study is a Phase 2 clinical study to evaluate the potential therapeutic benefits of TNX-102 SL for PTSD in members of the military and its veterans.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right